Skip to main content
padlock icon - secure page this page is secure

A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy

Buy Article:

$59.00 + tax (Refund Policy)

Summary Background 

Lipodystrophies are a heterogeneous group of diseases characterized by abnormal fat distribution. Familial partial lipodystrophy 2 (FPLD2) is due to mutations in the LMNA gene. Previous studies have suggested that LMNA mutations 5′ to the nuclear localization signal (NLS) are more likely to underlie laminopathies with cardiac or skeletal muscle involvement, while mutations 3′ to the NLS are more likely to underlie lipodystrophy and progeroid syndromes. Objective 

To study the clinical and molecular features of a subject with FPLD. Subjects and methods 

We carried out mutational analysis of LMNA gene in a woman with FPLD phenotype and in her relatives. Insulin resistance was evaluated by minimal model. Body composition was evaluated by dual-energy X-ray absorptiometry (DEXA). Echocardiography was done in affected subjects. 3T3-L1 preadipocytes were transfected with wild-type or mutant prelamin A constructs. In transfected cells, lamin A was detected using a Cy3-conjugated monoclonal anti-FLAG antibody. Results 

The patient showed atypical fat distribution, insulin resistance, severe aortic stenosis and hypertrophic cardiomyopathy. She has an affected 11-year-old son, not yet lipodystrophic but with an incipient aortic disease. LMNA sequencing showed that mother and son were both heterozygous for a novel c.1772G > T missense mutation in exon 11, which causes the substitution of the cysteine at residue 591 by a phenylalanine (C591F). In mouse preadipocytes transfected with the mutant human LMNA gene, the mutant lamin A isoform was mislocated in the nucleus. Conclusions 

This patient shows a novel clinical form of FPLD2, due to a mutation affecting lamin A only, with cardiac involvement.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Thyroid and Metabolic Diseases Unit (UETeM), Department of Medicine, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain, 2: IGM-CNR Unit of Bologna c/o IOR, Bologna, Italy, 3: Division of Cardiology, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, Spain, 4: Division of Endocrinology, Hospital Arquitecto Marcide, O Ferrol, Spain and 5: Unit of Hypertension and Vascular Risk, Department of Internal Medicine, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, Spain

Publication date: July 1, 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more